CV Sciences, Inc. (CVSI) stock
CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-21.13%)
Close on Oct 19, 2026Market cap $2.53MP/E –Yield –
CV Sciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
CV Sciences's profit margin for the twelve months ending Sep 30, 2026 was -13.7%. For fiscal 2025 it was -6.9%, against -15.2% the year before. The highest annual figure on record is 20.7% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -6.9% | +8.3 |
| FY2024 | Dec 31, 2024 | -15.2% | −34.6 |
| FY2023 | Dec 31, 2023 | 19.4% | +70.1 |
| FY2022 | Dec 31, 2022 | -50.7% | +26.9 |
| FY2021 | Dec 31, 2021 | -77.6% | +13.6 |
| FY2020 | Dec 31, 2020 | -91.2% | −60.3 |
| FY2019 | Dec 31, 2019 | -30.9% | −51.7 |
| FY2018 | Dec 31, 2018 | 20.7% | +44.4 |
| FY2017 | Dec 31, 2017 | -23.7% | +104.2 |
| FY2016 | Dec 31, 2016 | -127.9% | −21.7 |
| FY2015 | Dec 31, 2015 | -106.1% | −93.2 |
| FY2014 | Dec 31, 2014 | -12.9% | +93.9 |
| FY2013 | Dec 31, 2013 | -106.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -3.1% | +8.7 |
| Q2 FY2026 | Jun 30, 2026 | -26.0% | −18.8 |
| Q1 FY2026 | Mar 31, 2026 | -20.1% | −17.1 |
| Q4 FY2025 | Dec 31, 2025 | -6.2% | +12.5 |
| Q3 FY2025 | Sep 30, 2025 | -11.7% | +0.1 |
| Q2 FY2025 | Jun 30, 2025 | -7.2% | +7.6 |
| Q1 FY2025 | Mar 31, 2025 | -3.0% | +12.7 |
| Q4 FY2024 | Dec 31, 2024 | -18.7% | +4.2 |
| Q3 FY2024 | Sep 30, 2024 | -11.8% | −0.9 |
| Q2 FY2024 | Jun 30, 2024 | -14.8% | +17.7 |
| Q1 FY2024 | Mar 31, 2024 | -15.7% | −153.3 |
| Q4 FY2023 | Dec 31, 2023 | -22.9% | +36.9 |
| Q3 FY2023 | Sep 30, 2023 | -10.9% | +16.6 |
| Q2 FY2023 | Jun 30, 2023 | -32.5% | +31.6 |
| Q1 FY2023 | Mar 31, 2023 | 137.6% | +187.4 |
| Q4 FY2022 | Dec 31, 2022 | -59.8% | +118.5 |
| Q3 FY2022 | Sep 30, 2022 | -27.5% | −26.7 |
| Q2 FY2022 | Jun 30, 2022 | -64.1% | +4.7 |
| Q1 FY2022 | Mar 31, 2022 | -49.9% | +14.7 |
| Q4 FY2021 | Dec 31, 2021 | -178.2% | +0.5 |
| Q3 FY2021 | Sep 30, 2021 | -0.8% | +56.0 |
| Q2 FY2021 | Jun 30, 2021 | -68.8% | +17.9 |
| Q1 FY2021 | Mar 31, 2021 | -64.6% | −2.3 |
| Q4 FY2020 | Dec 31, 2020 | -178.8% | −107.1 |
| Q3 FY2020 | Sep 30, 2020 | -56.7% | −42.7 |
| Q2 FY2020 | Jun 30, 2020 | -86.7% | −94.0 |
| Q1 FY2020 | Mar 31, 2020 | -62.3% | +0.6 |
| Q4 FY2019 | Dec 31, 2019 | -71.7% | −92.1 |
| Q3 FY2019 | Sep 30, 2019 | -14.0% | −38.3 |
| Q2 FY2019 | Jun 30, 2019 | 7.3% | −18.5 |
| Q1 FY2019 | Mar 31, 2019 | -62.9% | −70.6 |
| Q4 FY2018 | Dec 31, 2018 | 20.4% | +13.9 |
| Q3 FY2018 | Sep 30, 2018 | 24.2% | +34.8 |
| Q2 FY2018 | Jun 30, 2018 | 25.8% | +50.1 |
| Q1 FY2018 | Mar 31, 2018 | 7.7% | +108.2 |
| Q4 FY2017 | Dec 31, 2017 | 6.5% | +270.7 |
| Q3 FY2017 | Sep 30, 2017 | -10.6% | – |
| Q2 FY2017 | Jun 30, 2017 | -24.3% | – |
| Q1 FY2017 | Mar 31, 2017 | -100.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -264.2% | – |
See a number that looks wrong?